Longitudinal effects of cyclosporine administration at 0 to 60 months after heart transplantation.
Costanzo
M R
MR
Department of Medicine, Loyola University Chicago, Maywood, Illinois.
Beto
J A
JA
Potempa
L D
LD
Bansal
V K
VK
Heroux
A L
AL
Kao
W G
WG
Pifarre
R
R
Johnson
M R
MR
D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D001379:Azathioprine / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D005919:Glomerular Filtration Rate / Q000187:drug effects*; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects / Q000379:methods; D007677:Kidney Function Tests; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D011241:Prednisone / Q000627:therapeutic use; D012189:Retrospective Studies; D013997:Time Factors
D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone